Discontinuation of Low-dose Acetylsalicylic Acid Treatment for Secondary Prevention of Cardiovascular Outcomes: Incidence and Predictors

Nov-10

AUTHORS : Dr Luis A. Garcia Rodríguez, Spanish Centre for Pharmacoepidemiologic Research (CEIFE), Almirante 28, 28004 Madrid, Spain – Email: lagarcia@ceife.es – Profile: http://www.ceife.es/quienes-somos.html

JOURNAL : Value in Health

REFERENCE: 13(7):A344

DOI : 10.1016/S1098-3015(11)72366-X

Discontinuation of Low-dose Acetylsalicylic Acid Treatment for Secondary Prevention of Cardiovascular Outcomes: Incidence and Predictors

More publications

Comparative effect of aspirin versus clopidogrel monotherapy on incident type 2 diabetes in patients with atherosclerotic cardiovascular diseases: A target trial emulation study

Postoperative Weight Loss After Antiobesity Medications and Revision Risk After Joint Replacement

Comparative effectiveness and prescribing trends of modified release versus immediate release indapamide in patients with hypertension: cohort study